{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T11:29:29Z","timestamp":1791890969227,"version":"4.3.4"},"reference-count":85,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2005,10,1]],"date-time":"2005-10-01T00:00:00Z","timestamp":1128124800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2005,10,1]],"date-time":"2005-10-01T00:00:00Z","timestamp":1128124800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seminars in Hematology"],"published-print":{"date-parts":[[2005,10]]},"DOI":"10.1053\/j.seminhematol.2005.05.019","type":"journal-article","created":{"date-parts":[[2005,11,3]],"date-time":"2005-11-03T08:58:14Z","timestamp":1131008294000},"page":"221-229","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"title":["Role of Tyrosine Kinases and Phosphatases in Polycythemia Vera"],"prefix":"10.1053","volume":"42","author":[{"given":"Zhizhuang Joe","family":"Zhao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William","family":"Vainchenker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanford B.","family":"Krantz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicole","family":"Casadevall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan N.","family":"Constantinescu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1053\/j.seminhematol.2005.05.019_bib1","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/S0092-8674(00)81688-8","article-title":"Signaling\u20142000 and beyond","volume":"100","author":"Hunter","year":"2000","journal-title":"Cell"},{"key":"10.1053\/j.seminhematol.2005.05.019_bib2","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1038\/35077225","article-title":"Oncogenic kinase signalling","volume":"411","author":"Blume-Jensen","year":"2001","journal-title":"Nature"},{"key":"10.1053\/j.seminhematol.2005.05.019_bib3","doi-asserted-by":"crossref","first-page":"1912","DOI":"10.1126\/science.1075762","article-title":"The protein kinase complement of the human genome","volume":"298","author":"Manning","year":"2002","journal-title":"Science"},{"key":"10.1053\/j.seminhematol.2005.05.019_bib4","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1016\/j.cell.2004.05.018","article-title":"Protein tyrosine phosphatases in the human genome","volume":"117","author":"Alonso","year":"2004","journal-title":"Cell"},{"key":"10.1053\/j.seminhematol.2005.05.019_bib5","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1096\/fj.02-1212rev","article-title":"A genomic perspective on protein tyrosine phosphatases","volume":"18","author":"Andersen","year":"2004","journal-title":"FASEB J"},{"key":"10.1053\/j.seminhematol.2005.05.019_bib6","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1126\/science.1082596","article-title":"Mutational analysis of the tyrosine kinome in colorectal cancers","volume":"300","author":"Bardelli","year":"2003","journal-title":"Science"},{"key":"10.1053\/j.seminhematol.2005.05.019_bib7","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1146\/annurev.immunol.22.012703.104753","article-title":"The BCR-ABL story","volume":"22","author":"Wong","year":"2004","journal-title":"Annu Rev Immunol"},{"key":"10.1053\/j.seminhematol.2005.05.019_bib8","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1126\/science.1096096","article-title":"Mutational analysis of the tyrosine phosphatome in colorectal cancers","volume":"304","author":"Wang","year":"2004","journal-title":"Science"},{"key":"10.1053\/j.seminhematol.2005.05.019_bib9","doi-asserted-by":"crossref","first-page":"4272","DOI":"10.1182\/blood-2001-12-0349","article-title":"Polycythemia vera","volume":"100","author":"Spivak","year":"2002","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2005.05.019_bib10","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1016\/S0140-6736(96)91338-0","article-title":"Pathogenesis of polycythemia vera","volume":"347","author":"Green","year":"1996","journal-title":"Lancet"},{"key":"10.1053\/j.seminhematol.2005.05.019_bib11","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1097\/00062752-199903000-00008","article-title":"Molecular basis for polycythemia","volume":"6","author":"Prchal","year":"1999","journal-title":"Curr Opin Hematol"},{"key":"10.1053\/j.seminhematol.2005.05.019_bib12","doi-asserted-by":"crossref","first-page":"1382","DOI":"10.1056\/NEJM197406132902419","article-title":"Bone-marrow responses in polycythemia vera","volume":"290","author":"Prchal","year":"1974","journal-title":"N Engl J Med"},{"key":"10.1053\/j.seminhematol.2005.05.019_bib13","doi-asserted-by":"crossref","first-page":"1982","DOI":"10.1182\/blood.V84.6.1982.1982","article-title":"Anti-erythropoietin (EPO) receptor monoclonal antibodies distinguish EPO-dependent and EPO-independent erythroid progenitors in polycythemia vera","volume":"84","author":"Fisher","year":"1994","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2005.05.019_bib14","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1182\/blood.V83.1.99.99","article-title":"Circulating erythroid progenitors in polycythemia vera are hypersensitive to insulin-like growth factor-1 in vitro","volume":"83","author":"Correa","year":"1994","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2005.05.019_bib15","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1172\/JCI108706","article-title":"Erythroid colony formation by polycythemia vera bone marrow in vitro. Dependence on erythropoietin","volume":"59","author":"Zanjani","year":"1977","journal-title":"J Clin Invest"},{"key":"10.1053\/j.seminhematol.2005.05.019_bib16","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1182\/blood.V59.2.447.447","article-title":"Erythroid progenitors in polycythemia vera","volume":"59","author":"Casadevall","year":"1982","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2005.05.019_bib17","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1172\/JCI115009","article-title":"Polycythemia vera blood burst-forming units erythroid are hypersensitive to interleukin-3","volume":"87","author":"Dai","year":"1991","journal-title":"J Clin Invest"},{"key":"10.1053\/j.seminhematol.2005.05.019_bib18","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1182\/blood.V80.4.891.891","article-title":"Polycythemia vera. II. Hypersensitivity of bone marrow erythroid, granulocyte-macrophage, and megakaryocyte progenitor cells to interleukin-3 and granulocyte-macrophage colony-stimulating factor","volume":"80","author":"Dai","year":"1992","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2005.05.019_bib19","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1111\/j.1365-2141.1994.tb03246.x","article-title":"Polycythemia vera. III. Burst forming units-erythroid (BFU-E) response to stem cell factor and c-kit receptor expression","volume":"86","author":"Dai","year":"1994","journal-title":"Br J Haematol"},{"key":"10.1053\/j.seminhematol.2005.05.019_bib20","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1182\/blood.V86.3.877.877","article-title":"Increased basal and induced tyrosine phosphorylation of the insulin-like growth factor I receptor beta subunit in circulating mononuclear cells of patients with polycythemia vera","volume":"86","author":"Mirza","year":"1995","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2005.05.019_bib21","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1172\/JCI114303","article-title":"Erythropoietin receptors in polycythemia vera","volume":"84","author":"Means","year":"1989","journal-title":"J Clin Invest"},{"key":"10.1053\/j.seminhematol.2005.05.019_bib22","doi-asserted-by":"crossref","first-page":"1862","DOI":"10.1182\/blood.V89.6.1862","article-title":"Insulin-like growth factor binding protein-1 is elevated in patients with polycythemia vera and stimulates erythroid burst formation in vitro","volume":"89","author":"Mirza","year":"1997","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2005.05.019_bib23","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1056\/NEJM197610212951702","article-title":"Polycythemia vera","volume":"295","author":"Adamson","year":"1976","journal-title":"N Engl J Med"},{"key":"10.1053\/j.seminhematol.2005.05.019_bib24","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1056\/NEJMoa025217","article-title":"A tyrosine kinase created by fusion of the PDGFRA and FIP1L1 genes as a therapeutic target of imatinib in idiopathic hypereosinophilic syndrome","volume":"348","author":"Cools","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1053\/j.seminhematol.2005.05.019_bib25","doi-asserted-by":"crossref","first-page":"5712","DOI":"10.1073\/pnas.95.10.5712","article-title":"Fibroblast growth factor receptor 1 is fused to FIM in stem-cell myeloproliferative disorder with t(8;13)","volume":"95","author":"Popovici","year":"1998","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1053\/j.seminhematol.2005.05.019_bib26","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1016\/S0889-8588(03)00089-3","article-title":"Mast cell proliferative disorders","volume":"17","author":"Valent","year":"2003","journal-title":"Hematol Oncol Clin North Am"},{"key":"10.1053\/j.seminhematol.2005.05.019_bib27","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1097\/00062752-200203000-00002","article-title":"New insights into erythropoiesis","volume":"9","author":"Koury","year":"2002","journal-title":"Curr Opin Hematol"},{"key":"10.1053\/j.seminhematol.2005.05.019_bib28","doi-asserted-by":"crossref","first-page":"2958","DOI":"10.1096\/fasebj.5.14.1752362","article-title":"Signal transduction in erythropoiesis","volume":"5","author":"Mason-Garcia","year":"1991","journal-title":"FASEB J"},{"key":"10.1053\/j.seminhematol.2005.05.019_bib29","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1126\/science.2326648","article-title":"Erythropoietin retards DNA breakdown and prevents programmed death in erythroid progenitor cells","volume":"248","author":"Koury","year":"1990","journal-title":"Science"},{"key":"10.1053\/j.seminhematol.2005.05.019_bib30","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1182\/blood.V77.3.419.419","article-title":"Erythropoietin","volume":"77","author":"Krantz","year":"1991","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2005.05.019_bib31","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/0092-8674(93)90414-L","article-title":"JAK2 associates with the erythropoietin receptor and is tyrosine phosphorylated and activated following stimulation with erythropoietin","volume":"74","author":"Witthuhn","year":"1993","journal-title":"Cell"},{"key":"10.1053\/j.seminhematol.2005.05.019_bib32","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/0092-8674(95)90234-1","article-title":"Generation of committed erythroid BFU-E and CFU-E progenitors does not require erythropoietin or the erythropoietin receptor","volume":"83","author":"Wu","year":"1995","journal-title":"Cell"},{"key":"10.1053\/j.seminhematol.2005.05.019_bib33","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/S0303-7207(01)00489-0","article-title":"Alterations of the insulin-like growth factor system in patients with polycythemia vera","volume":"181","author":"Michl","year":"2001","journal-title":"Mol Cell Endocrinol"},{"key":"10.1053\/j.seminhematol.2005.05.019_bib34","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/S0092-8674(00)81168-X","article-title":"Jak2 deficiency defines an essential developmental checkpoint in definitive hematopoiesis","volume":"93","author":"Neubauer","year":"1998","journal-title":"Cell"},{"key":"10.1053\/j.seminhematol.2005.05.019_bib35","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1016\/S1097-2765(01)00401-4","article-title":"The N-terminal domain of Janus kinase 2 is required for Golgi processing and cell surface expression of erythropoietin receptor","volume":"8","author":"Huang","year":"2001","journal-title":"Mol Cell"},{"key":"10.1053\/j.seminhematol.2005.05.019_bib36","doi-asserted-by":"crossref","first-page":"27251","DOI":"10.1074\/jbc.M501376200","article-title":"Janus kinases affect thrombopoietin receptor cell surface localization and recycling","volume":"280","author":"Royer","year":"2005","journal-title":"J Biol Chem"},{"key":"10.1053\/j.seminhematol.2005.05.019_bib37","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1056\/NEJM199802263380903","article-title":"Impaired expression of the thrombopoietin receptor by platelets from patients with polycythemia vera","volume":"338","author":"Moliterno","year":"1998","journal-title":"N Engl J Med"},{"key":"10.1053\/j.seminhematol.2005.05.019_bib38","doi-asserted-by":"crossref","first-page":"2555","DOI":"10.1182\/blood.V94.8.2555.420k14_2555_2561","article-title":"Posttranslational processing of the thrombopoietin receptor is impaired in polycythemia vera","volume":"94","author":"Moliterno","year":"1999","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2005.05.019_bib39","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/S0301-472X(01)00789-5","article-title":"Acquired uniparental disomy of chromosome 9p is a frequent stem cell defect in polycythemia vera","volume":"30","author":"Kralovics","year":"2002","journal-title":"Exp Hematol"},{"key":"10.1053\/j.seminhematol.2005.05.019_bib40","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1016\/S0301-472X(01)00637-3","article-title":"STAT3 is constitutively active in some patients with polycythemia rubra vera","volume":"29","author":"Roder","year":"2001","journal-title":"Exp Hematol"},{"key":"10.1053\/j.seminhematol.2005.05.019_bib41","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.exphem.2004.10.017","article-title":"Increased erythropoiesis in polycythemia vera is associated with increased erythroid progenitor proliferation and increased phosphorylation of Akt\/PKB","volume":"33","author":"Dai","year":"2005","journal-title":"Exp Hematol"},{"key":"10.1053\/j.seminhematol.2005.05.019_bib42","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.exphem.2003.11.003","article-title":"Multiple signaling pathways are involved in erythropoietin-independent differentiation of erythroid progenitors in polycythemia vera","volume":"32","author":"Ugo","year":"2004","journal-title":"Exp Hematol"},{"key":"10.1053\/j.seminhematol.2005.05.019_bib43","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1016\/S0301-472X(03)00085-7","article-title":"Spontaneous STAT5 activation induces growth factor independence in idiopathic myelofibrosis","volume":"31","author":"Komura","year":"2003","journal-title":"Exp Hematol"},{"key":"10.1053\/j.seminhematol.2005.05.019_bib44","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1056\/NEJM199802263380902","article-title":"Expression of Bcl-x in erythroid precursors from patients with polycythemia vera","volume":"338","author":"Silva","year":"1998","journal-title":"N Engl J Med"},{"key":"10.1053\/j.seminhematol.2005.05.019_bib45","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1016\/S0140-6736(05)71142-9","article-title":"Acquired mutation of the tyrosine kinase JAK2 in human myeloproliferative disorders","volume":"365","author":"Baxter","year":"2005","journal-title":"Lancet"},{"key":"10.1053\/j.seminhematol.2005.05.019_bib46","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1038\/nature03546","article-title":"unique clonal JAK2 mutation leading to constitutive signalling causes polycythaemia vera","volume":"434","author":"James","year":"2005","journal-title":"Nature"},{"key":"10.1053\/j.seminhematol.2005.05.019_bib47","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/j.ccr.2005.03.023","article-title":"Activating mutation in the tyrosine kinase JAK2 in polycythemia vera, essential thrombocythemia, and myeloid metaplasia with myelofibrosis","volume":"7","author":"Levine","year":"2005","journal-title":"Cancer Cell"},{"key":"10.1053\/j.seminhematol.2005.05.019_bib48","doi-asserted-by":"crossref","first-page":"1779","DOI":"10.1056\/NEJMoa051113","article-title":"A gain of function mutation of Jak2 in patients with myeloproliferative disorders","volume":"352","author":"Kralovics","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1053\/j.seminhematol.2005.05.019_bib49","doi-asserted-by":"crossref","first-page":"22788","DOI":"10.1074\/jbc.C500138200","article-title":"Identification of an acquired JAK2 mutation in polycythemia vera","volume":"280","author":"Zhao","year":"2005","journal-title":"J Biol Chem"},{"key":"10.1053\/j.seminhematol.2005.05.019_bib50","doi-asserted-by":"crossref","DOI":"10.1182\/blood-2005-03-1183","article-title":"The JAK2 V617F activating tyrosine kinase mutation is an infrequent event in both \u201catypical\u201d myeloprolioferative disorders and the myelodysplastic syndrome","author":"Steensma","year":"2005","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2005.05.019_bib51","doi-asserted-by":"crossref","first-page":"1562","DOI":"10.1128\/MCB.17.3.1562","article-title":"Mutation in the Jak kinase JH2 domain hyperactivates Drosophila and mammalian Jak-Stat pathways","volume":"17","author":"Luo","year":"1997","journal-title":"Mol Cell Biol"},{"key":"10.1053\/j.seminhematol.2005.05.019_bib52","doi-asserted-by":"crossref","first-page":"3387","DOI":"10.1128\/MCB.20.10.3387-3395.2000","article-title":"Regulation of the Jak2 tyrosine kinase by its pseudokinase domain","volume":"20","author":"Saharinen","year":"2000","journal-title":"Mol Cell Biol"},{"key":"10.1053\/j.seminhematol.2005.05.019_bib53","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.1091\/mbc.e02-06-0342","article-title":"Autoinhibition of Jak2 tyrosine kinase is dependent on specific regions in its pseudokinase domain","volume":"14","author":"Saharinen","year":"2003","journal-title":"Mol Biol Cell"},{"key":"10.1053\/j.seminhematol.2005.05.019_bib54","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1093\/protein\/14.1.27","article-title":"Prediction of the structure of human Janus kinase 2 (JAK2) comprising the two carboxy-terminal domains reveals a mechanism for autoregulation","volume":"14","author":"Lindauer","year":"2001","journal-title":"Protein Eng"},{"key":"10.1053\/j.seminhematol.2005.05.019_bib55","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1126\/science.278.5341.1309","article-title":"A TEL-JAK2 fusion protein with constitutive kinase activity in human leukemia","volume":"278","author":"Lacronique","year":"1997","journal-title":"Science"},{"key":"10.1053\/j.seminhematol.2005.05.019_bib56","doi-asserted-by":"crossref","first-page":"1596","DOI":"10.1182\/blood.V100.5.1596.h81702001596_1596_1601","article-title":"Predictive values of X-chromosome inactivation patterns and clinicohematologic parameters for vascular complications in female patients with essential thrombocythemia","volume":"100","author":"Shih","year":"2002","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2005.05.019_bib57","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/S0165-4608(02)00678-7","article-title":"Karyotypic abnormalities in myelofibrosis following polycythemia vera","volume":"140","author":"Andrieux","year":"2003","journal-title":"Cancer Genet Cytogenet"},{"key":"10.1053\/j.seminhematol.2005.05.019_bib58","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/S0968-0004(98)01331-0","article-title":"The N-termini of FAK and JAKs contain divergent band 4.1 domains","volume":"24","author":"Girault","year":"1999","journal-title":"Trends Biochem Sci"},{"key":"10.1053\/j.seminhematol.2005.05.019_bib59","doi-asserted-by":"crossref","first-page":"4379","DOI":"10.1073\/pnas.081069198","article-title":"Ligand-independent oligomerization of cell-surface erythropoietin receptor is mediated by the transmembrane domain","volume":"98","author":"Constantinescu","year":"2001","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1053\/j.seminhematol.2005.05.019_bib60","doi-asserted-by":"crossref","first-page":"3574","DOI":"10.1182\/blood.V89.10.3574","article-title":"Polycythemia vera. V. Enhanced proliferation and phosphorylation due to vanadate are diminished in polycythemia vera erythroid progenitor cells","volume":"89","author":"Dai","year":"1997","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2005.05.019_bib61","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1182\/blood.V90.2.651","article-title":"Identification of increased protein tyrosine phosphatase activity in polycythemia vera erythroid progenitor cells","volume":"90","author":"Sui","year":"1997","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2005.05.019_bib62","doi-asserted-by":"crossref","first-page":"4354","DOI":"10.1182\/blood-2003-04-1308","article-title":"PTP-MEG2 is activated in polycythemia vera erythroid progenitor cells and is required for growth and expansion of erythroid cells","volume":"102","author":"Xu","year":"2003","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2005.05.019_bib63","doi-asserted-by":"crossref","unstructured":"Aravind L, Neuwals AF, Ponting CP: Sec14p-like domains in NF1 and Dbl-like proteins indicate lipid regulation of Ras and Rho signaling. Curr Biol 9:R195-R197, 999","DOI":"10.1016\/S0960-9822(99)80127-4"},{"key":"10.1053\/j.seminhematol.2005.05.019_bib64","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1002\/jcb.10195","article-title":"Purification and characterization of protein tyrosine phosphatase PTP-MEG2","volume":"6","author":"Qi","year":"2002","journal-title":"J Cell Biochem"},{"key":"10.1053\/j.seminhematol.2005.05.019_bib65","doi-asserted-by":"crossref","first-page":"22609","DOI":"10.1074\/jbc.M301560200","article-title":"Specific interaction of protein tyrosine phosphatase-MEG2 with phosphatidylserine","volume":"278","author":"Zhao","year":"2003","journal-title":"J Biol Chem"},{"key":"10.1053\/j.seminhematol.2005.05.019_bib66","doi-asserted-by":"crossref","first-page":"2620","DOI":"10.1074\/jbc.M104550200","article-title":"Protein-tyrosine phosphatase MEG2 is expressed by human neutrophils. Localization to the phagosome and activation by polyphosphoinositides","volume":"277","author":"Kruger","year":"2002","journal-title":"J Biol Chem"},{"key":"10.1053\/j.seminhematol.2005.05.019_bib67","doi-asserted-by":"crossref","first-page":"6661","DOI":"10.4049\/jimmunol.171.12.6661","article-title":"Homotypic secretory vesicle fusion induced by the protein tyrosine phosphatase MEG2 depends on polyphosphoinositides in T cells","volume":"171","author":"Huynh","year":"2003","journal-title":"J Immunol"},{"key":"10.1053\/j.seminhematol.2005.05.019_bib68","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/S0968-0004(03)00091-4","article-title":"The \u201cShp\u201ding news","volume":"28","author":"Neel","year":"2003","journal-title":"Trends Biochem Sci"},{"key":"10.1053\/j.seminhematol.2005.05.019_bib69","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1038\/ng0693-124","article-title":"Motheaten and viable motheaten mice have mutations in the hematopoietic cell phosphatase gene","volume":"4","author":"Tsui","year":"1993","journal-title":"Nat Genet"},{"key":"10.1053\/j.seminhematol.2005.05.019_bib70","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1016\/0092-8674(93)90369-2","article-title":"Mutations at the murine motheaten locus are within the hematopoietic cell protein tyrosine phosphatase (Hcph) gene","volume":"73","author":"Shultz","year":"1993","journal-title":"Cell"},{"key":"10.1053\/j.seminhematol.2005.05.019_bib71","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1016\/0092-8674(95)90351-8","article-title":"Specific recruitment of SH-PTP1 to the erythropoietin receptor causes inactivation of JAK2 and termination of proliferative signals","volume":"80","author":"Klingmuller","year":"1995","journal-title":"Cell"},{"key":"10.1053\/j.seminhematol.2005.05.019_bib72","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1038\/sj.onc.1200942","article-title":"The gene encoding hematopoietic cell phosphatase (SHP-1) is structurally and transcriptionally intact in polycythemia vera","volume":"14","author":"Asimakopoulos","year":"1997","journal-title":"Oncogene"},{"key":"10.1053\/j.seminhematol.2005.05.019_bib73","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1111\/j.1600-0609.1997.tb01692.x","article-title":"No evidence for an altered mRNA expression or protein level of hematopoietic cell phosphatase in CD34+ bone marrow progenitor cells or mature peripheral blood cells in polycythemia vera","volume":"59","author":"Anderson","year":"1997","journal-title":"Eur J Haematol"},{"key":"10.1053\/j.seminhematol.2005.05.019_bib74","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1016\/S0301-472X(99)00043-0","article-title":"Defective expression of the SHP-1 phosphatase in polycythemia vera","volume":"27","author":"Wickrema","year":"1999","journal-title":"Exp Hematol"},{"issue":"suppl 3","key":"10.1053\/j.seminhematol.2005.05.019_bib75","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1053\/j.seminhematol.2004.02.011","article-title":"The chronic myeloproliferative disorders","volume":"41","author":"Spivak","year":"2004","journal-title":"Semin Hematol"},{"key":"10.1053\/j.seminhematol.2005.05.019_bib76","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1038\/ng772","article-title":"Mutations in PTPN11, encoding the protein tyrosine phosphatase SHP-2, cause Noonan syndrome","volume":"29","author":"Tartaglia","year":"2001","journal-title":"Nat Genet"},{"key":"10.1053\/j.seminhematol.2005.05.019_bib77","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1038\/ng1156","article-title":"Somatic mutations in PTPN11 in juvenile myelomonocytic leukemia, myelodysplastic syndromes and acute myeloid leukemia","volume":"34","author":"Tartaglia","year":"2003","journal-title":"Nat Genet"},{"key":"10.1053\/j.seminhematol.2005.05.019_bib78","doi-asserted-by":"crossref","first-page":"2325","DOI":"10.1182\/blood-2003-09-3287","article-title":"Mutations in PTPN11 implicate the SHP-2 phosphatase in leukemogenesis","volume":"103","author":"Loh","year":"2004","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2005.05.019_bib79","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1182\/blood-2003-11-3876","article-title":"Genetic evidence for lineage- and differentiation stage-related contribution of somatic PTPN11 mutations to leukemogenesis in childhood acute leukemia","volume":"104","author":"Tartaglia","year":"2004","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2005.05.019_bib80","doi-asserted-by":"crossref","first-page":"8816","DOI":"10.1158\/0008-5472.CAN-04-1923","article-title":"Activating mutations of the Noonan syndrome-associated SHP2\/PTPN11 gene in human solid tumors and adult acute myelogenous leukemia","volume":"64","author":"Bentires-Alj","year":"2004","journal-title":"Cancer Res"},{"key":"10.1053\/j.seminhematol.2005.05.019_bib81","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1006\/excr.1999.4668","article-title":"Shp-2 tyrosine phosphatase","volume":"253","author":"Feng","year":"1999","journal-title":"Exp Cell Res"},{"key":"10.1053\/j.seminhematol.2005.05.019_bib82","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1097\/00000441-200303000-00007","article-title":"Polycythemia vera responds to imatinib mesylate","volume":"325","author":"Jones","year":"2003","journal-title":"Am J Med Sci"},{"key":"10.1053\/j.seminhematol.2005.05.019_bib83","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1038\/sj.leu.2402938","article-title":"Imatinib mesylate (Gleevec) reduces phlebotomy requirements in polycythemia vera","volume":"17","author":"Silver","year":"2003","journal-title":"Leukemia"},{"key":"10.1053\/j.seminhematol.2005.05.019_bib84","doi-asserted-by":"crossref","first-page":"2240","DOI":"10.1182\/blood-2003-03-0676","article-title":"Imatinib mesylate inhibits autonomous erythropoiesis in patients with polycythemia vera in vitro","volume":"102","author":"Oehler","year":"2003","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2005.05.019_bib85","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S1534-5807(01)00114-9","article-title":"Quality control of receptor-kinase signaling complexes","volume":"2","author":"Bonifacino","year":"2002","journal-title":"Dev Cell"}],"container-title":["Seminars in Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S003719630500079X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S003719630500079X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,22]],"date-time":"2025-09-22T06:17:21Z","timestamp":1758521841000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S003719630500079X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,10]]},"references-count":85,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2005,10]]}},"alternative-id":["S003719630500079X"],"URL":"https:\/\/doi.org\/10.1053\/j.seminhematol.2005.05.019","relation":{},"ISSN":["0037-1963"],"issn-type":[{"value":"0037-1963","type":"print"}],"subject":[],"published":{"date-parts":[[2005,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Role of Tyrosine Kinases and Phosphatases in Polycythemia Vera","name":"articletitle","label":"Article Title"},{"value":"Seminars in Hematology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1053\/j.seminhematol.2005.05.019","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2005 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}